Fundamentals of Electronic Submissions and eCTD

Slides:



Advertisements
Similar presentations
17 September 2007ISO TC215 WG6 Brisbane1 Identification of Medicinal Products & Pharmacovigilance Task Forces.
Advertisements

The Information Professionals Role in Product Safety Jack Leitmeyer Director, Adverse Experience Information Management Worldwide Product Safety Merck.
EPAA Conference 5 November 2007 Georgette LALIS Enterprise and Industry DG European Commission The international dimension of regulatory acceptance.
EPAA Annual conference November Regulatory acceptance of alternative approaches for pharmaceuticals Jean-Marc Vidal Safety & Efficacy of Human Medicines.
Dr. Raghuveer Pharma Consultants D R P C Quality. Perfection. Confidentiality. D R P C Quality. Perfection. Confidentiality. 1.
Merton V. Smith, Ph.D., J.D. Director International Programs Center for Veterinary Medicine U.S. Food and Drug Administration Governance of Veterinary.
GMP Document and Record Retention
eCTD – A TOOL to QUICK /RELIABLE REGULATORY SUBMISSION
DRUG REGULATORY AFFAIRS
A Case Study in the Value of Harmonisation Yoshikazu HAYASHI Deputy Director Evaluation and Licensing Division Pharmaceutical & Food Safety Bureau Ministry.
Stefan Franzén Introduction to clinical trials.
Knowledge Update Clinical documentation: from preclinical studies to drug registration Split, 12 September 2008.
Training Workshop on Pharmaceutical Development with a Focus on Paediatric Medicines / October |1 | Regulatory Requirement on Dossier of Medicinal.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
Presented by: Karen Ginsbury For IFF, Denmark March 2012.
1 Revisions to 21 CFR Supplements and Other Changes to an Approved Application PhRMA Perspective FDA Public Meeting – 7 Feb 2007.
Biopharmaceutical Regulatory Requirements 40. Marketing Authorization for New Chemical Entities Health Canada’s (HC) Therapeutic Products Directorate.
Documentation of bioequivalence Drs. J. Welink Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October 2009.
EFPIA EFPIA IT Proposals ppt Slide 1 EFPIA Proposals for IT Support to the European Regulatory Procedures Mr S. Hasler EFPIA PAT Regulation 2000.
Justina A. Molzon, MS Pharm, JD
On ICH Feb. 13, 2013 Toshi Tominaga Ph. D. Food and Drug Evaluation Center, Osaka City Univ. Hospital International Regulatory Harmonization Amid Globalization.
What is ICH? ICH is a joint initiative involving both regulators and research-based industry representatives of the EU, Japan and the US in scientific.
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA. Presentation by: Dr. Joseph K. Yano B.Pharm (Nbi) L.L.B (Moi) Legal Officer Pharmacy and Poisons Board Ministry.
Stefan Franzén Introduction to clinical trials.
And Pharmaceuticals Health Technology Technical Cooperation for Essential Drugs and Traditional Medicine Challenges of Medicine Regulation in Africa Global.
DETERMINATION OF RELATED SUBSTANCES & IMPURITIES IN DRUGS BY ICH GUIDE LINES BY M.PAUL RICHARDS.
*The views expressed in this presentation are those of the presenter’s and do not necessarily represent the views of the U.S. Food and Drug Administration.
DEPARTMENT OF HEALTH Medicines Regulatory Affairs
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.
J. B. Chemicals & Pharmaceuticals Ltd. © Copyright 2005 J. B. Chemicals Pharma Ltd. Electronic Submissions – eCTD Advantages Dr Milind Joshi.
Research Study Data Standards Standards for research study data for submission to regulatory authorities Standard development divided into three parts:
ICH and CTD November 19, 2002 Kimberly Stranick, Ph.D. Worldwide Regulatory Affairs The Common Technical Document.
Anthony Serracino Inglott Chairman of the Malta Medicines Authority
WHO Workshop on Assessment of Bioequivalence Data Addis Ababa, 31. August – 3. September 2010 Selection of comparators Compiled by Jan Welink WHO Workshop.
FDA Office of Orphan Products Development
CTD Dossier Preparation K. Srikantha Reddy Sr
FDA ICH Public Meeting 5630 Fishers Lane, Rockville, MD May 8, :30 am -- 2:00 pm Implementation of the CTD Update-Issues-Next Steps Justina A. Molzon,
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
FDA Public Meeting Preparation for the ICH Meetings in Tokyo, Japan, Including Progress on the Common Technical Document and Possibilities for New Topics.
GMP- A Regulatory Perspective. Regulatory Perspective in entering Global Pharma Markets.
SAPRAA 5 Sept 2008 eCTD An overview of the full day presentation by Dr Olaf Schoepke at the SAAPI conference in July 2008.
1 COMMON TECHNICAL DOCUMENT / ORIGIN OF CTD… ICH EWG CTD WAS OFFICIALLY SIGNED OFF IN NOVEMBER 2000, AT 5 TH ICH CONFERENCE; SAN DIEGO,CALIFORNIA.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
China EU Pharmaceutical Forum
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
The First Conference for Medicines Regulatory Authorities In Sudan and Neighboring Countries Khartoum December 2014 Alain PRAT, Technical Officer,
E-Clinical
Implementation of PANDRH Guidelines NAFTA Region VI PANDRH Conference Brasilia, July 2-8, 2011 Justina Molzon -- US Food and Drug Administration Mike Ward.
INDEX WHAT IS ICH ? HISTORY INITIATION INTRODUCTION TOPICS QUALITY GUDILINES.
Abstract References Why CTD ? CTD is an ICH standard that FDA adopted in a consensus process, as a member of ICH, together with other member regions, Europe.
© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
Mutagenic Impurities: Guidances Update w/ CMC Perspectives
Regulatory– Terms & Definitions רגולציה - מונחים והגדרות
CTD Content Management
The Information Professional’s Role in Product Safety
ICH-GCP Avinash Kondawar M. Pharm Lead CRA
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Michelle Limoli, Pharm.D.
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Kimby N. Barton Interim Director Medical Devices Bureau
NASs approval time by therapeutic area:
JSS College of Pharmacy Ooty, Tamil Nadu Sunday, April 24th , 2016
What is ICH? ICH is a joint initiative involving both regulators and research-based industry representatives of the EU, Japan and the US in scientific.
Beyond Academia.
Percentage Key Message
Dr Manisha Shridhar Regional Advisor WHO-SEARO
THE HIGHLIGHTS OF DRUG REGULATION IN KENYA
Interconnection of good practices: from development to distribution
Presentation transcript:

Fundamentals of Electronic Submissions and eCTD TAKE Solutions Technology Analytics Knowledge Enterprise

Fundamentals of Electronic Submissions and eCTD Today's Presentation will be spreadover three main topics as below: Regulatory Guidance eCTD Technicalities Gap Analysis (in-house current regulatory operations vs recommended eCTD based regulatory operations)

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance Some Definition Submissions Formats • Paper Full submission in Hard copy as printed Text • Electronic Submission in CTD folder structure in a CD /DVD with or without supporting Hard copies for legal or other requirements of the individual Agency • eCTD Submission of Documents with a Xml backbone sent eitherin a CD/DVD or uploaded in the agencys’ portal (the definitions can be with animation )

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance Need For Regulatory Guidance The Constant changing Drug registration requirements is entering an Electronic Era The Scientists and Industry Experts require exposure on the current Electronic Documentation Practices This is the integration of Technical Knowledge, Regulatory Requirements and Information technology

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance INTRODUCTION Regulatory guidance on legislation and regulations: Regulatory guidance such as laws, decrees, orders and any legislative and regulatory material related to pharmacy, drug manufacturing, drug registration process, commerce, information, promotion and advertising, e-trade is available ( this slide may not be required at this place)

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance MAJOR AGENCIES IN REGULATED MARKET US: FOOD AND DRUG ADMINISTRATION (FDA) EU: EUROPEAN MEDICINES EVALUTION AGENCY (EMEA) EUROPEAN DIRECTORATE FOR QUALITY MEDICINES (EDQM) JAPAN: MINISTRY OF HEALTH ,LABOUR ANDWELFARE (MHLW) CANADA: HEALTH PRODUCT AND FOOD BRANCH (HEALTH CANADA)

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance Web link to Drug regulatory sites: http://mednet2.who.int/mdra/pilotstudy_websites.htm (one of the various sites in the net giving lists of Drug regulatory Agencies world wide)

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance Submission Types Investigational New Drug Application (IND) New Drug Application (NDA/ NDS) Abbreviated/Abridged New Drug Application (ANDA/ ANDS) Drug Master Files (DMF) Active Substance Master File (ASMF)

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance Large no of documents + Different format for Different Agencies means More complication to Manufacturer Solution = Harmonisation of document ICH

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance HISTORY & ROLE of ICH: ICH is – The International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use in the year ---- First initiative to streamline the technical requirements for drug regulatory registrations A Joint effort of Regulatory authorities and industry association

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance HISTORY & ROLE of ICH… continued Initiated by 6 Parties from European Union, Japan and USA -the EU, EFPIA, MHLW, JPMA, FDA and PhRMA. 3 Observers are WHO, EFTA, and Canada (represented by Health Canada) - acting as a link between the ICH and non-ICH countries and regions.

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance HISTORY & ROLE of ICH… continued ICH Guidelines: The ICH Topics are divided into four major categories Q "Quality" Topics, - relating to chemical and pharmaceutical QualityAssurance. S "Safety" Topics, - relating to in vitro and in vivo pre-clinical studies. E "Efficacy" Topics, - relating to clinical studies in human subject. M "Multidisciplinary" Topics, - cross-cutting Topics which do not fit uniquely into one of the above categories.

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance HISTORY & ROLE of ICH… continued M "Multidisciplinary" Topics, are grouped as M1: Medical Terminology (MedDRA) M2: Electronic Standards for Transmission of Regulatory Information (ESTRI) M3: Timing of Pre-clinical Studies in Relation to Clinical Trials M4: The Common Technical Document (CTD) M5: Data Elements and Standards for Drug Dictionaries

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance

Fundamentals of Electronic Submissions and eCTD Regulatory Guidance

Fundamentals of Electronic Submissions and eCTD eCTD Technicalities

Fundamentals of Electronic Submissions and eCTD Gap Analysis

DRUG MASTER FILES Thank You